MCL1 and gastric cancer: Given the role of STAT3 and SRF in mediating the transcription response of MCL1 to HER2-targeting drugs in GC cells, we next explored whether targeting STAT3 or SRF also synergized with BCLXLi to kill HER2-amplified GC cells.